Agenus Inc. (AGEN)
Develops antibody drugs to help immune systems fight cancer and infectious diseases
$6.60+0.08%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+23.1%
The outlook
AGEN is trading above both its 50- and 200-day averages, positioned roughly two-thirds of the way through its 52-week range. Analyst targets average around 355% above the current price, though coverage details aren't specified. The stock carries a trailing P/E of 3.2 and a bullish sentiment score of 86/100.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range65% of the way from its 52-week low to high
Price targetAvg target +355% vs current price
Market cap
$274.8M
52-wk high
$8.70
52-wk low
$2.71
50-day avg
$3.74
200-day avg
$3.72
Trailing P/E
3.2